advertisement
Stewart WC 5
Showing records 1 to 5 | Display all abstracts from Stewart WC11977 Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
Sharpe ED; Henry CJ; Mundorf TK; Day DG; Stewart JA; Jenkins JN; Stewart WC
Eye 2005; 19: 35-40
11691 Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies
Bayer A; Weiler W; Oeverhaus U; Skrotzki F-E; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 470-478
11843 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects
Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
Ophthalmology 2005; 112: 603-608
11842 Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients
Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
Ophthalmology 2005; 112: 262-266
11996 Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment
Stewart WC; Konstas AGP; Pfeiffer N
Journal of Ocular Pharmacology and Therapeutics 2004; 20: 461-469
